EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive de l'UMR1027, unité mixte INSERM - Université Toulouse III Paul Sabatier
2020
Manceau C, Roumiguié M, Lesourd M, Beauval JB, Almeras C, Aziza R, Gautier JR, Loison G, Meyrigna O, Salin A, Tollon C, Soulié M, Malavaud B, Ploussard G. Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions [published online ahead of print, 2020 Apr 17]. Urol Oncol. 2020;S1078-1439(20)30129-0. doi:10.1016/j.urolonc.2020.03.023.
Pfister C, Gravis G, Fléchon A, Soulié M, Guy L, Laguerre B, Mottet N, Joly F, Allory Y, Harter V, Culine S; VESPER Trial Investigators. Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses. Eur Urol. 2020 Aug 28:S0302-2838(20)30641-2. doi: 10.1016/j.eururo.2020.08.024.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance. World J Urol. 2020;38(3):663‐671. doi:10.1007/s00345-019-02848-x.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance. World J Urol. 2020 Mar;38(3):663-671. doi: 10.1007/s00345-019-02848-x.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R , Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies. Urology. 2020;137:126‐132. doi:10.1016/j.urology.2019.10.039.
Ploussard G, Beauval JB, Renard-Penna R, Lesourd M, Manceau C, Almeras C, Gautier JR, Loison G, Portalez D, Salin A, Soulié M, Tollon C , Malavaud B, Roumiguié M. Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction. J Clin Med. 2020;9(1):225. doi:10.3390/jcm9010225.
Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study. World J Urol. 2020 Jul;38(7):1735-1740. doi: 10.1007/s00345-019-02973-7.
Prudhomme T, Benoit T, Mittal S, Roumiguié M, Mesnard B, Broudeur L, Kervella D, Sallusto F, Doumerc N, Binhazzaa M, Iborra F, Soulié M, Blancho G, Kamar N, Thuret R, Karam G, Gamé X, Branchereau J, Living-donor kidney transplantation: comparison of sequential and simultaneous surgical organizations. Int Urol Nephrol. 2020;52(5):865‐876. doi:10.1007/s11255-019-02366-0.
Prudhomme T, Marquette T, Péré M, Patard PM, Michiels C, Sallusto F, Rigaud J, Glémain P, Kamar N, Blancho G, Soulié M, Rischmann P, Karam G, Gamé X, Robert G, Branchereau J. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate. J Endourol. 2020;34(2):184‐191. doi:10.1089/end.2019.0430.
Roumiguie M, Lesourd M, Zgheib J, Tollon C, Salin A, Alméras C, Doumerc N, Thoulouzan M, Soulié M, Gautier JR, Loison G, Assoun J, Vacher A, Aziza R, Malavaud B, Beauval JB, Ploussard G. Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features. Urol Oncol. 2020;38(5):386‐392. doi:10.1016/j.urolonc.2019.12.018.
Sargos P, Chabaud S, Latorzeff I, Magné N, Benyoucef A, Supiot S, Pasquier D, Abdiche MS, Gilliot O, Graff-Cailleaud P, Silva M, Bergerot P, Baumann P, Belkacemi Y, Azria D, Brihoum M, Soulié M, Richaud P. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol. 2020 Oct;21(10):1341-1352. doi: 10.1016/S1470-2045(20)30454-X.
Thurin NH, Rouyer M, Gross-Goupil M, Rebillard X, Soulié M, Haaser T, Roumiguié M, Le Moulec S, Capone C, Pierrès M, Lamarque S, Jové J, Bignon E, Droz-Perroteau C, Moore N, Blin P. Epidemiology of metastatic castration-resistant prostate cancer: A first estimate of incidence and prevalence using the French nationwide healthcare database. Cancer Epidemiol. 2020 Oct 14;69:101833. doi: 10.1016/j.canep.2020.101833.
2019
Bery N, Keller L, Soulié M, Gence R, Iscache AL, Cherier J, Cabantous S, Sordet O, Lajoie-Mazenc I, Pedelacq JD, Favre G, Olichon A. A Targeted Protein Degradation Cell-Based Screening for Nanobodies Selective toward the Cellular RHOB GTP-Bound Conformation. Cell Chem Biol. 2019 Nov 21;26(11):1544-1558.e6. doi: 10.1016/j.chembiol.2019.08.009.
Gas J, Nouhaud FX, Roumiguié M, Lagarde S, Delchier MC, Huyghe É, Soulié M, Gamé X, Beauval JB. Management of urinary-tract fistulas using reversible balloon nephrostomy: a single-center retrospective analysis of 56 patients. Int Urogynecol J. 2019. Feb 0 (2), 287-29 doi:10.1007/s00192-018-3628-0.
Laclergerie F, Delchier MC, Covin B, Sallusto F, Soulie M, Gamé X, Beauval JB, Kamar N, Roumiguié M, Doumerc N. Robot-assisted laparoscopic partial nephrectomy with renal artery clamping using an endovascular balloon catheter for an allograft kidney tumor: A new perspective to manage renal vascular control? Am J Transplant. 2019 Apr;19(4):1239-1240. doi: 10.1111/ajt.15151.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging. J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418.
Prudhomme T, Roumiguié M, Benoit T, Lesourd M, Beauval JB, Doumerc N, Sallusto F, Soulié M, Kamar N, Gamé X. Laparoscopy for living donor left nephrectomy: Comparison of three-dimensional and two-dimensional vision. Clin Transplant. 2019. 33 (12), e13745. doi:10.1111/ctr.13745.
Zgheib J, Roumiguie M, Soulie M, Covin B, Huyghe E. Migration of an abdominal mesh into a reconstructed ileal neobladder, diagnosis and management: A case report. Urol Case Rep. 2019 Feb 14;24:100846. doi: 10.1016/j.eucr.2019.100846.
